Clinical Trial Update: Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire [Phase 2]

View source ↗

Summary

Phase 2 study of BP101 in women with Hypoactive sexual desire disorder has completed. The update reports on efficacy and safety findings from the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder

Drugs mentioned

• BP101 (BP101)

Snippet

Sponsor: Ivix LLX | Conditions: Hypoactive Sexual Desire Disorder (HSDD) | Phase 2 | Status: COMPLETED